Genkyotex S.A.
Records under this name other than patents Genkyotex S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,073,919 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,389,518 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,974,791 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,772,891 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,130,619 | Amido thiadiazole derivatives as NADPH oxidase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,096,588 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held Surrendered on reissue Surrendered on reissue May 5, 2026 · USPTO record | Surrendered on reissue | Surrendered on reissue May 5, 2026 | USPTO record |
| US 8,481,562 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held Lapsed on the fee record Ended Jul 9, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 9, 2025 | USPTO record |
| US 8,455,485 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held Lapsed on the fee record Ended Jun 4, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 4, 2025 | USPTO record |
| US 8,455,486 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held Lapsed on the fee record Ended Jun 4, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 4, 2025 | USPTO record |
| US 9,012,449 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors Formerly held Lapsed on the fee record Ended Apr 21, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2023 | USPTO record |